High carbohydrates consumption and inflammatory bowel diseases

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 1, 2011, Pages 87-90

  El Tawil, A M ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Caucasians; Complex carbohydrates; Epidemiology; Inflammatory bowel diseases; Outraged immune response

Indexed keywords

BETA GLUCAN; CARBOHYDRATE; GLUCAN; HEXOSE; SUGAR; T LYMPHOCYTE RECEPTOR;

ASIAN; BEVERAGE; CARBOHYDRATE INTAKE; CARBOHYDRATE METABOLISM; CAUCASIAN; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENTERITIS; GRANULOCYTE; HUMAN; IMMUNOSTIMULATION; INTESTINE ABSORPTION; LOW CARBOHYDRATE DIET; LYMPHOCYTE; MACROPHAGE; NONHUMAN; REVIEW; ULCERATIVE COLITIS; AGED; ARTICLE; CARBOHYDRATE DIET; IMMUNOLOGY; MIDDLE AGED;

AGED; DIETARY CARBOHYDRATES; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTES; MIDDLE AGED;

EID: 79953146068     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. MARTINI GA, BRANDES JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 1976; 54: 367-371.
2. MILLER B, FERVERS F, ROHBECK R, STROHMEYER G. Sugar consumption in patients with Crohn's disease. Verh Dtsch Ges Inn Med 1976; 82.
3. MAYBERRY JE RHODES J, NEWCOMBE RG. Breakfast and dietary aspects of Crohn's disease. Br Med J 1978; 2(6149): 1401.
4. GRAHAM WB, TORRANCE B, TAYLOR TV. Breakfast and Crohn's disease. Br Med J 1978; II: 768.
5. THORNTON JR, EMMETT PM, HEATON KW. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979; 2(6193): 762-764.
6. KASPER H, SOMMER H. Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr 1979; 32: 1898-1901.
7. MAYBERRY JF, RHODES J, NEWCOMBE RG. Increased sugar consumption in Crohn's disease. Digestion 1980; 20: 323-326.
8. SILKOFF K, HALLAK A, YEGENA L, ROZEN P, MAYBERRY JF, RHODES J, NEWCOMBE RG. Consumption of refined carbohydrate by patients with Crohn's disease in Tel-Aviv-Yafo. Postgrad Med J 1980; 56: 842-846.
9. MAYBERRY JF, RHODES J, ALLAN R, NEWCOMBE RG, REGAN GM, CHAMBERLAIN LM, WRAGG KG. Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981; 26: 444-448.
10. JÄRNEROT G, JÄRNMARK I, NILSSON K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983; 18: 999-1002.
11. PENNY WJ, MAYBERRY JF, AGGETT PJ, GILBERT JO, NEWCOMBE RG, RHODES J. Relationship between trace elements, sugar consumption, and taste in Crohn's disease. Gut 1983; 24: 288-292.
12. BIANCHI PORRO G, PANZA E. Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) 1985; 291: 971-972.
13. KATSCHINSKI B, LOGAN RF, EDMOND M, LANGMAN MJ. Smoking and sugar intake are separate but interactive risk factors in Crohn's disease. Gut 1988; 29: 1202-1206.
14. PERSSON PG, AHLBOM A, HELLERS G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3: 47-52.
15. SCHUTZ T, DRUDE C, PAULISCH E, LANGE KP, LOCHS H. Sugar intake, taste changes and dental health in Crohn's disease. Dig Dis 2003; 21: 252-257.
16. VAN DER HORST V, WESSO I, BURGER AP, DIETRICH DLL, GROBLER SR. Chemical analysis of cool drinks and pure fruit juices- some clinical implications. S Afr Med J 1984; 66: 755-758.
17. BARRETT KE, BARMAN SM, BOITANO S, BROOKS HL. Digestion, absorption, & nutrition principles. In: Ganong's Review of Medical Physiology. 23rd ed. McGraw Hill Lange. New York, USA. 2010, pp: 451-467.
18. LEFRANCOIS L, FULLER B, HULLEAT JW, OLSON S, PUDDINGTON L. On the front lines: intraepithelial lymphocytes as primary effectors of mucosal immunity. Springer Semin Immunopathol 1997; 18: 463-475.
19. LEFRANCOIS L, PUDDINGTON L. BASIC ASPECTS OF INTRAEPITHELIAL LYMPOHCYTES IMMUNOLOGY. IN: OGRA PL, MESTECKY J, LAMM ME, et al. eds. Mucosal immunology, 2nd ed. San Diego, CA: Academic press, 1999, pp. 413-428.
20. ERNST PB, BEFUS AD, BIENENSTOCK J. Leukocytes in the intestinal epithelium: an unusual immunologic comartment. Immunol Today 1985; 6: 50-56.
21. LEFRANCOIS L, GOODMAN T. In vivo modulation of cytolytic activity and Thy 1 expression in TCR-γδ + intraepithelial lymphocytes. Science 1989; 243: 1716-1780.
22. KIYONO H, MCGHEE JR. Mucosal immunology: intraepithelial lymphocytes. Advances in host defense mechanisms. Vol 9: Mucosal immunology: intraepithelial lymphocytes. New York. Raven press, 1994.
23. FUJHASHI K, TAGUCHI T, AICHER WK, MCGHEE JR, BLUESTONE JA, ELDRIGE JH, KIYONO H. Immunoregulatory functions for murine intraepithelial lymphocytes: γ/β T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while α/β TCR+ T cells provide B cell help. J Exp Med 1992; 175: 695-707.
24. + murine intestinal intraepithelial lymphocytes. Int Immunol 1990; 2: 361-365.
25. TAGUCHI T, AICHER WK, FUJHASHI K, YAMAMOTO M, MCGHEE JR, BLUESTONE JA, KIYONO H. Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, γ/β T cells produce IFN- γ and IL-5. J Immunol 1991; 147: 3736-3744.
26. PROBERT CS, CHOTT A, SAUBERMANN LJ, STEVENS AC, BALK SP, BLUMBERG RS. Prevalence of an ulcerative colitis-associated CD8+ T cell receptor beta-chain CDR3-region motif and its association with disease activity. J Clin Immunol 2001; 21: 126-134.
27. NUSSLER NC, STANGE B, HOFFMAN RA, SCHRAUT WH, BAUER AJ, NEUHAUS P. Enhanced cytolytic activity of intestinal intraepithelial lymphocytes in patients with Crohn's disease. Langenbecks Arch Surg 2000; 385: 218-224.
28. BRANDES JW, LORENZ-MEYER H. Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Z Gastroenterol 1981; 19: 1-12.
29. KASHKINA MA, FRE DUN IS. [Macrophage activation by polysaccharides from yeast-like fungi]. Biull Eksp Biol Med 1980; 89: 439-441.
30. VETVICKA V, THORNTON BP, ROSS GD. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 1996; 98: 50-61.
31. BURGALETA C, GOLDE DW. Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res 1977; 37: 1739-1742.
32. HIDA TH, KAWAMINAMI H, ISHIBASHI K, MIURA NN, ADACHI Y, YADOMAE T, OHNO N. Effect of GM-CSF on cytokine induction by soluble beta-glucan SCG in vitro in beta-glucan-treated mice. Microbiol Immunol 2009; 53: 391-402.
33. BAKER WH, NOLD JB, PATCHEN ML, JACKSON WE. Histopathologic effects of soluble glucan and WR-2721, independently and combined in C3H/HeN mice. Proc Soc Exp Biol Med 1992; 201: 180-191.
34. PATCHEN ML, MACVITTIE TJ, WATHEN LM. Effects of pre- and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage and erythroid progenitor cells, and hemopoietic stromal cells. Experientia 1984; 40: 1240-1244.
35. SOUTHON S, GEE JM, BAYLISS CE, WYATT GM, HORN N, JOHNSON IT. Intestinal microflora, morphology and enzyme activity in zinc-deficient and Zn-supplemented rats. Br J Nutr 1986; 55: 603-611.
36. RAO NL, RILEY JP, BANIE H, XUE X, SUN B, CRAWFORD S, LUNDEEN KA, Yu F, KARLSSON L, FOURIE AM, DUNFORD PJ. Leukotriene A4 hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 2010; 181: 899-907.